Bee Tin Goh

Prof. Dr. Bee Tin Goh

National Dental Centre of Singapore, Singapore City, Singapore
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2021 in Advanced Functional Materials
Verified
Journal Article
Open access
PDF file
RSRazina Z. Seeni
Razina Z. Seeni
MZMengjia Zheng
Mengjia Zheng
DLDaniel Chin Shiuan Lio
Daniel Chin Shiuan Lio
CWChristian Wiraja
Christian Wiraja
MYMohammad Firdaus Bin Mohd Yusoff
Mohammad Firdaus Bin Mohd Yusoff
Chenjie XuChenjie Xu
Chenjie Xu
Pain management during dental procedures is a cornerstone for successful daily practice. In current practice, the traditional needle and syringe injection is used to administer local anesthesia. However, the appearance of long needles and the pain associated with it often leads to dental anxiety deterring timely interventions. Microneedles (MNs) have emerged as a minimally invasive alternative to hypodermic needles and shown to be effective in transdermal drug delivery applications. In this article, the potential use of MNs for local anesthesia delivery in dentistry is explored. The development of a novel conductive MN array that can be used in combination with iontophoresis technique to achieve drug penetration through the oral mucosa and the underlying bone tissue is presented. The conductive MN array plays a dual‐role, creating micro‐conduits and lowering the resistance of the oral mucosa. The reduced tissue resistance further enhances the application of a low‐voltage current that is able to direct and accelerate the drug molecules to target the sensory nerves supplying teeth. The successful delivery of lidocaine using this new strategy in a clinically relevant rabbit incisor model is shown to be as effective as the current gold standard.

3 December 2017 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
THThanuja D. K. Herath
Thanuja D. K. Herath
ALAnis Larbi
Anis Larbi
STSwee Hin Teoh
Swee Hin Teoh
CKC. James Kirkpatrick
C. James Kirkpatrick
BGBee Tin Goh
Bee Tin Goh
Repair and regeneration of critical-sized bone defects remain a major challenge in orthopaedic and craniomaxillofacial surgery. Until now, attempts to bioengineer bone tissue have been hindered by the inability to establish proper angiogenesis and osteogenesis in the tissue construct. In the present study, we established a novel triple cell co-culture model consisting of osteoblasts, endothelial cells, and neutrophils and conducted a systematic investigation of the effects of neutrophils on angiogenesis and osteogenesis. Neutrophils significantly increased angiogenesis in the tissue construct, evidenced by the formation of microvessel-like structures with an extensive lattice-like, stable tubular network in the co-culture model. Moreover, neutrophils significantly induced the expression of pro-angiogenic markers, such as VEGF-A, CD34, EGF, and FGF-2 in a dose- and time-dependent manner. Subsequently, PCR arrays corroborated that neutrophils upregulate the important angiogenic markers and MMPs. Moreover, neutrophils also enhanced osteogenic markers, such as ALP, OCN, OPN, and COL-1 compared with the controls. As shown by the osteogenic gene arrays, neutrophils significantly regulated major osteogenic markers such as BMP2, BMP3, BMP4, BMP5, TGF-β2, RUNX2, and ECM proteins. Significantly higher mineralization was observed in triple cell co-culture compared with controls. Foregoing data indicate that the triple cell co-culture model can be used to stimulate the growth of microvasculature within a bone bioengineering construct to improve cell viability. Neutrophil-mediated enhancement of angiogenesis and osteogenesis could be a viable, clinically relevant tissue engineering strategy to obtain optimal bone growth in defect sites, in the field of oral and maxillofacial surgery.

Verified
Journal Article
Open access
PDF file
CLChau Sang Lau
Chau Sang Lau
SPSo Yeon Park
So Yeon Park
LELalith Prabha Ethiraj
Lalith Prabha Ethiraj
PSPriti Singh
Priti Singh
GRGrace Raj
Grace Raj
BGBee Tin Goh
Bee Tin Goh
Bone regeneration involves multiple factors such as tissue interactions, an inflammatory response, and vessel formation. In the event of diseases, old age, lifestyle, or trauma, bone regeneration can be impaired which could result in a prolonged healing duration or requiring an external intervention for repair. Currently, bone grafts hold the golden standard for bone regeneration. However, several limitations hinder its clinical applications, e.g., donor site morbidity, an insufficient tissue volume, and uncertain post-operative outcomes. Bone tissue engineering, involving stem cells seeded onto scaffolds, has thus been a promising treatment alternative for bone regeneration. Adipose-derived mesenchymal stem cells (AD-MSCs) are known to hold therapeutic value for the treatment of various clinical conditions and have displayed feasibility and significant effectiveness due to their ease of isolation, non-invasive, abundance in quantity, and osteogenic capacity. Notably, in vitro studies showed AD-MSCs holding a high proliferation capacity, multi-differentiation potential through the release of a variety of factors, and extracellular vesicles, allowing them to repair damaged tissues. In vivo and clinical studies showed AD-MSCs favoring better vascularization and the integration of the scaffolds, while the presence of scaffolds has enhanced the osteogenesis potential of AD-MSCs, thus yielding optimal bone formation outcomes. Effective bone regeneration requires the interplay of both AD-MSCs and scaffolds (material, pore size) to improve the osteogenic and vasculogenic capacity. This review presents the advances and applications of AD-MSCs for bone regeneration and bone tissue engineering, focusing on the in vitro, in vivo, and clinical studies involving AD-MSCs for bone tissue engineering.

Verified
Journal Article
Open access
PDF file
THThanuja Darshani Herath
Thanuja Darshani Herath
LSLeonardo Saigo
Leonardo Saigo
BSBenoit Schaller
Benoit Schaller
ALAnis Larbi
Anis Larbi
Swee Hin TeohSwee Hin Teoh
Swee Hin Teoh
BGBee Tin Goh
Bee Tin Goh
Reconstruction of bone due to surgical removal or disease-related bony defects is a clinical challenge. It is known that the immune system exerts positive immunomodulatory effects on tissue repair and regeneration. In this study, we evaluated the in vivo efficacy of autologous neutrophils on bone regeneration using a rabbit calvarial defect model. Methods: Twelve rabbits, each with two surgically created calvarial bone defects (10 mm diameter), were randomly divided into two groups; (i) single application of neutrophils (SA-NP) vs. SA-NP control, and (ii) repetitive application of neutrophils (RA-NP) vs. RA-NP control. The animals were euthanized at 4 and 8 weeks post-operatively and the treatment outcomes were evaluated by micro-computed tomography, histology, and histomorphometric analyses. Results: The micro-CT analysis showed a significantly higher bone volume fraction (bone volume/total volume) in the neutrophil-treated groups, i.e., median interquartile range (IQR) SA-NP (18) and RA-NP (24), compared with the untreated controls, i.e., SA-NP (7) and RA-NP (14) at 4 weeks (p < 0.05). Similarly, new bone area fraction (bone area/total area) was significantly higher in neutrophil-treated groups at 4 weeks (p < 0.05). Both SA-NP and RA-NP had a considerably higher bone volume and bone area at 8 weeks, although the difference was not statistically significant. In addition, immunohistochemical analysis at 8 weeks revealed a higher expression of osteocalcin in both SA-NP and RA-NP groups. Conclusions: The present study provides first hand evidence that autologous neutrophils may have a positive effect on promoting new bone formation. Future studies should be performed with a larger sample size in non-human primate models. If proven feasible, this new promising strategy could bring clinical benefits for bone defects to the field of oral and maxillofacial surgery.

28 January 2022 in International Journal of Bioprinting
Verified
Journal Article
Open access
PDF file
YLYuchun Liu
Yuchun Liu
Swee Leong SingSwee Leong Sing
Swee Leong Sing
RLRebecca Xin En Lim
Rebecca Xin En Lim
WYWai Yee Yeong
Wai Yee Yeong
BGBee Tin Goh
Bee Tin Goh
Additive manufacturing has proven to be a viable alternative to conventional manufacturing methodologies for metallic implants due to its capability to customize and fabricate novel and complex geometries. Specific to its use in dental applications, various groups have reported successful outcomes for customized root-analog dental implants in preclinical and clinical studies. However, geometrical accuracy of the fabricated samples has never been analyzed. In this article, we studied the geometric accuracy of a 3D printed titanium dental implant design against the tooth root of the monkey maxilla incisor. Monkey maxillas were scanned using cone-beam computed tomography, then segmentation of the incisor tooth roots was performed before the fabrication of titanium dental implants using a laser powder bed fusion (PBF) process. Our results showed 68.70% ± 5.63 accuracy of the 3D printed dental implant compared to the actual tooth (n = 8), where main regions of inaccuracies were found at the tooth apex. The laser PBF fabrication process of the dental implants showed a relatively high level of accuracy of 90.59% ± 4.75 accuracy (n = 8). Our eventual goal is to develop an accurate workflow methodology to support the fabrication of patient-specific 3D-printed titanium dental implants that mimic patients’ tooth anatomy and fit precisely within the socket upon tooth extraction. This is essential for promoting primary stability and osseointegration of dental implants in the longer term.

16 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
CLChau Sang Lau
Chau Sang Lau
JCJasper Chua
Jasper Chua
SPSomasundaram Prasadh
Somasundaram Prasadh
Jing LimJing Lim
Jing Lim
LSLeonardo Saigo
Leonardo Saigo
BGBee Tin Goh
Bee Tin Goh
Alveolar ridge augmentation is an important dental procedure to increase the volume of bone tissue in the alveolar ridge before the installation of a dental implant. To meet the high demand for bone grafts for alveolar ridge augmentation and to overcome the limitations of autogenous bone, allografts, and xenografts, researchers are developing bone grafts from synthetic materials using novel fabrication techniques such as 3D printing. To improve the clinical performance of synthetic bone grafts, stem cells with osteogenic differentiation capability can be loaded into the grafts. In this pilot study, we propose a novel bone graft which combines a 3D-printed polycaprolactone–tricalcium phosphate (PCL-TCP) scaffold with adipose-derived mesenchymal stem cells (AD-MSCs) that can be harvested, processed and implanted within the alveolar ridge augmentation surgery. We evaluated the novel bone graft in a porcine lateral alveolar defect model. Radiographic analysis revealed that the addition of AD-MSCs to the PCL-TCP scaffold improved the bone volume in the defect from 18.6% to 28.7% after 3 months of healing. Histological analysis showed the presence of AD-MSCs in the PCL-TCP scaffold led to better formation of new bone and less likelihood of fibrous encapsulation of the scaffold. Our pilot study demonstrated that the loading of AD-MSCs improved the bone regeneration capability of PCL-TCP scaffolds, and our novel bone graft is suitable for alveolar ridge augmentation.